caprolactone has been researched along with oxazoles in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan Kwon, I; Cheon Lee, S; Chung, H; Kim, C; Young Jeong, S | 1 |
| Kelly, AM; Wiesbrock, F | 1 |
| Baixiang, D; Baiyang, L; Dandan, Z; Hongmei, L; Jun, L; Leran, B; Li, Y; Rutong, Y; Yandong, X; Yufu, Z; Zhen, W | 1 |
3 other study(ies) available for caprolactone and oxazoles
| Article | Year |
|---|---|
Polymeric micelles of poly(2-ethyl-2-oxazoline)-block-poly(epsilon-caprolactone) copolymer as a carrier for paclitaxel.
Topics: Animals; Caproates; Cell Line, Tumor; Drug Carriers; Humans; Lactones; Male; Micelles; Oxazoles; Paclitaxel; Polymers; Rats; Rats, Sprague-Dawley | 2003 |
Strategies for the synthesis of poly(2-oxazoline)-based hydrogels.
Topics: Aldehydes; Amines; Caproates; Dioxanes; Epoxy Compounds; Gamma Rays; Hydrogels; Hydrogen Bonding; Isocyanates; Lactones; Metals; Oxazoles; Oxidation-Reduction; Polymerization; Temperature | 2012 |
Reduction-responsive PEtOz-SS-PCL micelle with tailored size to overcome blood-brain barrier and enhance doxorubicin antiglioma effect.
Topics: Animals; Antineoplastic Agents; Biological Transport; Blood-Brain Barrier; Caproates; Cell Survival; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Liberation; Glioma; Lactones; Male; Mice; Mice, Inbred ICR; Micelles; Oxazoles; Particle Size; Polymers; Tissue Distribution | 2017 |